There Is No Reason Humira Should Cost $38,000 Per Year. Ending Patent Abuse Will Help Solve This.
Humira, a patent prescribed drug with no generic options, costs over $38,000 per year. Why? The lack of regulation of drug prices,...
At Long Last: A Promising First Step Toward Reducing Drug Prices
This morning, Health and Human Services Secretary Alex Azar gave a speech at the Brookings Institution about the administration's plan to...
How Patent Thickets Block More Affordable Drugs: The Case of Humira
The drug manufacturer AbbieVie Inc. has thrown up a formidable shield of patents around its drug Humira, preventing cheaper versions of...
New York Considering Blocking Merger of Aetna and CVS
Recently on October 10th, the Department of Justice approved the proposed merger of the health insurance company Aetna and the drugstore...
NY Department of Financial Services Hearing on CVS/Aetna Merger
Maria Vullo, the New York State Superintendent of Financial Services had a pro-consumer tone. She said she has a duty to protect...
Bipartisan Drug Pricing Reform
Senators Susan Collins (R-Maine), Claire McCaskill (D-Missouri), and Debbie Stabenow (D-Michigan) championed the “Patient Right to Know...
President Trump Signs Bills to Lower Cost of Drugs
This afternoon, President Trump signed two bipartisan bills into law today intended to lower patients’ prescription costs: Know the...
United States-Mexico-Canada Agreement (USMCA)
On Sunday, the US, Canada, and Mexico replaced NAFTA with the United States-Mexico-Canada Agreement (USMCA) after over a year of talks....
